Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
Authors:
- Bruce E. StroberBSBruce E. Strober
- Yves PoulinYPYves Poulin
- Francisco A. KerdelFKFrancisco A. Kerdel
- Richard G. LangleyRLRichard G. Langley
- Yihua GuYGYihua Gu
- Shiraz R. GuptaSGShiraz R. Gupta
- Martin M. OkunMOMartin M. Okun
- Kim A. PappKPKim A. Papp
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 64 (4) , 671-681
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- European S3‐Guidelines on the systemic treatment of psoriasis vulgarisJournal of the European Academy of Dermatology and Venereology, 2009
- Adalimumab treats psoriasis in patients previously treated with etanercept: A case seriesJournal of the American Academy of Dermatology, 2009
- Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritisBritish Journal of Dermatology, 2008
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2008
- Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasisBritish Journal of Dermatology, 2007
- Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practiceRheumatology, 2007
- Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasisJournal of Dermatological Treatment, 2007
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Initial experience with routine administration of etanercept in psoriasisBritish Journal of Dermatology, 2006
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003